Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Share Us

Webinar On The FDA Drug Approval Process

View: 1830

Website | Edit Freely

Category Food, Drugs & Biologics

Deadline: April 30, 2104 | Date: April 30, 2104

Venue/Country: Mississauga, ON, Canada, Canada

Updated: 2014-04-26 20:04:04 (GMT+9)

Call For Papers - CFP

This web seminar provides an overview of the entire FDA Drug Approval Process. This seminar will cover FDA requirements from discovery.

We will begin by developing a molecule, testing it, going through the IND process, clinical testing and finally the NDA process. We will also discuss IND/NDA submission preparation, in-vitro studies, nonclinical studies and human clinical trials. Also discussed will be the underlying scientific and regulatory principles involved in the entire Drug Development Process. This web seminar will also provide a foundation of knowledge for those who require an understanding of the entire FDA Drug Approval Process.

Areas Covered in the Session :

Understand the FDA drug research requirements

Learn about IND process

Learn about Clinical testing requirements

Learn about NDA process

Learn about in-vitro and nonclinical testing

Who Will Benefit:

Regulatory Affairs Personnel

Quality Personnel

Clinical Personnel

Research Personnel

Manufacturing Personnel

Drug Discovery Personnel

Legal Personnel

Personnel who require a general understanding of the FDA Drug Approval Process

Contact us:

Compliance Trainings

5939 Candlebrook Ct,

Mississauga, ON L5V 2V6,


Customer Support :


Email :

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.